GlassScriptPhysician profile
Chris A Calaway
NPI 1639165640
$1,461.99
in general payments reported to CMS, 2019-2025
21 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $61.60 · 2021: $285 · 2022: $311 · 2023: $288 · 2024: $116 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533 · Entertainment: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.03 |
| Entertainment | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $354.45 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $151.41 | 2019-2025 | |
| Aerie Pharmaceuticals, INC. | $122.04 | 2019 | |
| Oyster Point Pharma, INC. | $117.95 | 2022-2025 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $84.41 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $82.52 | 2021-2023 | Cequa |
| Abbvie INC. | $69.15 | 2022-2025 | |
| Biotissue Holdings INC. | $68.08 | 2021-2024 | |
| Allergan, INC. | $58.22 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $40.68 | 2022-2025 | Infuse |
| Thea Pharma INC. | $39.89 | 2022-2023 | Iyuzeh |
| Shire North American Group INC | $39.60 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.04 | 2019-2021 | |
| Tearlab Corp | $31.01 | 2022 | |
| Alcon Vision LLC | $30.16 | 2025 | Precision7 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $26.78 | 2024 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $25.24 | 2021 | |
| Maculogix, INC. | $23.48 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $22.18 | 2021 | |
| Amgen INC. | $21.70 | 2024 | Tepezza |
| Optos, INC. | $14.00 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Calaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.